Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic. (27th November 2020)

• Record Type: Journal Article
• Authors: Bajis, Sahar; Applegate, Tanya L; Grebely, Jason; Matthews, Gail V; Dore, Gregory J
• Is Part Of: Journal of infectious diseases. Volume 222(2020)Supplement 9
• Page Start: S758
• Page End: S772
• Publication Date: 2020-11-27
• Subjects: direct-acting antivirals -- global health -- HCV -- HCV elimination -- testing strategies; Communicable diseases -- Periodicals; Diseases -- Causes and theories of causation -- Periodicals; Medicine -- Periodicals; Communicable Diseases -- Periodicals; Electronic journals; 616.9
• DOI: 10.1093/infdis/jiaa366
• Languages: English
• ISSNs: 0022-1899

Abstract

Abstract: The World Health Organization has set a goal to eliminate hepatitis C virus (HCV) infection as public health threat by 2030. Although the advent of highly effective and tolerable direct-acting antiviral therapy has paved the way for HCV elimination, most people with HCV infection remain undiagnosed and untreated globally, with striking disparities between high-income and low- to middle-income countries. Novel decentralized and cost-effective "test-and-treat" strategies are critically needed to identify the millions of people unaware of their status and link them to treatment.